
-
SC Pharmaceuticals NASDAQ:SCPH scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company's lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA.
Location: 2400 District Ave Ste 310, Massachusetts, 01803-5239, US | Website: www.scpharmaceuticals.com | Industry: Medicinal and Botanical Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
122.5M
Cash
92.63M
Avg Qtr Burn
-17.63M
Short % of Float
21.04%
Insider Ownership
11.40%
Institutional Own.
85.31%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
FUROSCIX (furosemide) Details Heart failure | Approved Quarterly sales | |
FUROSCIX (furosemide) Details Heart failure | Approved Quarterly sales | |
PDUFA Approval decision | ||
FUROSCIX Auto-Injector Injection (furosemide) Details Heart failure | sNDA Submission |